Fundamentals data is not available for this company.
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-25 | 43.76 | (474.55) | (723.67)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-26 | 139.69 | (452.36) | (664.33)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-27 | 342.93 | (318.72) | (400.50)¢ | n/a | n/a | n/a | n/a | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
Agios Pharmaceuticals to sell cancer portfolio t... | 21-Dec-2020 | ShareCast |
Currency | US Dollars |
Share Price | $ 39.07 |
Change Today | $ 2.79 |
% Change | 7.69 % |
52 Week High | $61.64 |
52 Week Low | $25.90 |
Volume | 1,312,145 |
Shares Issued | 58.68m |
Market Cap | $2,292.65m |
RiskGrade | 304 |
Strong Buy | 1 |
Buy | 4 |
Neutral | 4 |
Sell | 0 |
Strong Sell | 0 |
Total | 9 |
Time | Volume / Share Price |
16:00 | 146,973 @ $39.07 |
15:59 | 104 @ $39.08 |
15:59 | 181 @ $39.08 |
15:59 | 122 @ $39.06 |
15:59 | 100 @ $39.07 |
You are here: research